Tarks Pharmaceuticals Private Limited
About Tarks Pharmaceuticals Private Limited
Data last updated:
Tarks Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 December 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85100MH2018PTC318396. Its GSTIN is 27AAHCT0753F1ZE (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ananda Narayan Kadam and Surekha Ananda Kadam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Rashmi Starcity C Wing Room No 202 Achole Near To Achole Water Tank, Mumbai, Maharashtra, India – 401209.
As per the financials filed for FY 2025, the company reported a revenue of ₹99.68 Lakh, a growth of 2% compared to the previous year. For the same year it recorded a net loss of ₹1.17 Lakh (net margin -1.2%) and EBITDA of ₹52,387 (EBITDA margin 0.5%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 39% over five years.
As per MCA filings, the company has open charges of ₹8.88 Lakh on record.
Company details
Contact details
Tarks Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressRashmi Starcity C Wing Room No 202 Achole Near To Achole Water Tank, Mumbai, Maharashtra, India – 401209
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Tarks Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Tarks Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Tarks Pharmaceuticals Private Limited, buy the company report.
Financials of Tarks Pharmaceuticals Private Limited
FY 2025 filings availableTarks Pharmaceuticals Private Limited reported revenue of ₹99.68 Lakh (up 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 39% over five years, including 2% growth in the latest year. EBITDA fell 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹52,387 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.17 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.5% | ||||
| Net Profit Margin | -1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Tarks Pharmaceuticals Private Limited, buy the company report.
Board of directors of Tarks Pharmaceuticals Private Limited
Tarks Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ananda Narayan Kadam | Director | 17 Dec 2018 | 7 Years 10 Months | Current |
| Surekha Ananda Kadam | Director | 17 Dec 2018 | 7 Years 10 Months | Current |
Peer comparison
Tarks Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medisquare Pharmacy Private Limited | ₹99.84 Lakh (FY 2023) | -40.0% | Belgaum, Karnataka, India | |||
| Tarks Pharmaceuticals Private Limitedthis company | ₹99.68 Lakh (FY 2025) | -₹1.17 Lakh | -1.2% | 2.0% | Mumbai, Maharashtra, India | |
| Avtix Health (India) Private Limited | ₹99.44 Lakh (FY 2024) | -18.0% | Kolkata, West Bengal, India | |||
| Imhotef Pharmaceuticals Private Limited | ₹99.4 Lakh (FY 2025) | 14.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Tarks Pharmaceuticals Private Limited, buy the company report.
Auditor
Tarks Pharmaceuticals Private Limited is audited by SHILPI & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHILPI & CO | FY 2019 | 145539W |
Shareholding
The shareholding of Tarks Pharmaceuticals Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Tarks Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Jul 2023 | 100761648 | Others | ₹8.88 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Tarks Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tarks Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Tarks Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCT0753F1ZE | Maharashtra | Active | 21 Jan 2019 |
To see the full GST registrations and return filing status of Tarks Pharmaceuticals Private Limited, buy the company report.
Recent activity
Tarks Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Ananda Narayan Kadam was appointed as Director on 17 Dec 2018.
Frequently asked questions
Tarks Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 December 2018 (8+ years old) and is registered under CIN U85100MH2018PTC318396.
Tarks Pharmaceuticals has 2 current directors:
- Ananda Narayan Kadam - Director
- Surekha Ananda Kadam - Director
The latest financial statements of Tarks Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Tarks Pharmaceuticals is 27AAHCT0753F1ZE, registered in Maharashtra.
The CIN (Corporate Identification Number) of Tarks Pharmaceuticals is U85100MH2018PTC318396. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tarks Pharmaceuticals was incorporated on 17 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Tarks Pharmaceuticals by revenue are Medisquare Pharmacy Private Limited, Avtix Health (India) Private Limited, Imhotef Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (retail trading).
Ananda Narayan Kadam was appointed as Director on 17 Dec 2018. Surekha Ananda Kadam was appointed as Director on 17 Dec 2018.
The registered office of Tarks Pharmaceuticals is at Rashmi Starcity C Wing Room No 202 Achole Near To Achole Water Tank, Mumbai, Maharashtra, India – 401209.
Tarks Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Tarks Pharmaceuticals has open charges of ₹8.88 Lakh and no satisfied charges on record as per latest MCA filings.